
Creative Medical Technology
(NASDAQ) CELZ
Creative Medical Technology Financials at a Glance
Market Cap
$3.00M
Revenue (TTM)
$3.00K
Net Income (TTM)
-$5.76M
EPS (TTM)
-$1.85
P/E Ratio
-0.44
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$1.41
Volume
3,103,135
Open
$2.61
Price
$1.41
Volume
3,103,135
Open
$2.61
Previous Close
$1.41
Daily Range
$1.37 - $4.67
52-Week Range
$0.79 - $6.25
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$1.41
Volume
3,103,135
Open
$2.61
Previous Close
$1.41
Daily Range
$1.37 - $4.67
52-Week Range
$0.79 - $6.25
Estimated Earnings Date
Aug 14, 2026
CELZ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Creative Medical Technology
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Timothy Warbington
Headquarters
Phoenix, AZ 85012, US
CELZ Financials
Key Financial Metrics (TTM)
Gross Margin
-1993.17%
Operating Margin
-198049.63%
Net Income Margin
-192066.27%
Return on Equity
-88.50%
Return on Capital
-81.74%
Return on Assets
-89.46%
Earnings Yield
-2.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.00M
Shares Outstanding
3.70M
Volume
3.10M
Avg. Volume
99.23K
Financials (TTM)
Gross Profit
-$59.80K
Operating Income
-$5.94M
EBITDA
-$5.75M
Operating Cash Flow
-$5.59M
Capital Expenditure
$1.00
Free Cash Flow
-$5.59M
Cash & ST Invst.
$5.85M
Total Debt
$0.00
Creative Medical Technology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$3.00M
N/A
Market Cap/Employee
$748.75K
N/A
Employees
4
N/A
Net Income
-$1.41M
+14.2%
EBITDA
-$1.43M
+12.2%
Quarterly Fundamentals
Total Cash
$5.85M
-24.1%
Total Debt
$0.00
-100.0%
Accounts Receivable
$105.71K
N/A
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-89.46%
N/A
Return on Invested Capital
-96.88%
N/A
Free Cash Flow
-$1.32M
+16.9%
Operating Cash Flow
-$1.32M
+16.9%